Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 22, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ars Pharmaceuticals, Inc.
| 188.49K |
$1.06 | $199,998.84 | +4.57% | 4.32M |
Apr 19
| |||||||
Ars Pharmaceuticals, Inc.
| 188.49K |
$1.06 | $199,998.84 | +4.57% | 4.32M |
Apr 19
| |||||||
Ars Pharmaceuticals, Inc.
| -100.00K |
$9.28 | -$928,005.00 | -2.78% | 3.5M |
Apr 16
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -100.00K |
$9.28 | -$928,005.00 | -2.78% | 3.5M |
Apr 16
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -100.00K |
$9.28 | -$927,735.00 | -2.74% | 3.54M |
Apr 9
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -100.00K |
$9.28 | -$927,735.00 | -2.74% | 3.54M |
Apr 9
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| 1.4M |
$9.48 | $13,289,410.41 | +16.38% | 9.96M |
Mar 25 - Mar 27
| |||||||
Ars Pharmaceuticals, Inc.
| -97.61K |
$9.12 | -$890,322.34 | -2.61% | 3.65M |
Mar 22 - Mar 25
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -97.61K |
$9.12 | -$890,322.34 | -2.61% | 3.65M |
Mar 22 - Mar 25
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -2.39K |
$9.02 | -$21,572.06 | -0.06% | 3.74M |
Mar 19 - Mar 21
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -2.39K |
$9.02 | -$21,572.06 | -0.06% | 3.74M |
Mar 19 - Mar 21
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -100.00K |
$9.14 | -$913,681.28 | -2.64% | 3.69M |
Mar 13 - Mar 15
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -100.00K |
$9.14 | -$913,681.28 | -2.64% | 3.69M |
Mar 13 - Mar 15
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -3.78K |
$9.02 | -$34,100.58 | -0.07% | 5.54M |
Feb 29
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -3.78K |
$9.02 | -$34,100.58 | -0.07% | 5.54M |
Feb 29
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -99.48K |
$9.02 | -$897,368.26 | -1.76% | 5.55M |
Feb 26 - Feb 28
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
| -99.48K |
$9.02 | -$897,368.26 | -1.76% | 5.55M |
Feb 26 - Feb 28
|
Scheduled
| ||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
| 9.5M |
May 17 - Jan 2
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
| 9.5M |
May 17 - Jan 2
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Ars Pharmaceuticals, Inc.
| 86.26K |
$3.71 | $319,954.01 | +2,905.29% | 89.23K |
Sep 28 - Sep 29
| |||||||
Ars Pharmaceuticals, Inc.
| 2.7M |
$3.03 | $8,183,525.74 | +46.10% | 8.56M |
Sep 21
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
$4.49 | -$643,520.00 |
—
| 210.35K |
Sep 1
| |||||||
Ars Pharmaceuticals, Inc.
| 3.75M |
$6.20 | $23,250,000.00 | +178.00% | 5.86M |
Aug 29
| |||||||
Ars Pharmaceuticals, Inc.
| 500K |
$6.20 | $3,100,000.00 | +6.65% | 8.02M |
Aug 29
| |||||||
Ars Pharmaceuticals, Inc.
| 500K |
$6.20 | $3,100,000.00 | +6.65% | 8.02M |
Aug 29
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
$4.15 | -$259,334.22 |
—
| 210.35K |
Aug 3 - Aug 4
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
$4.20 | -$321,995.84 |
—
| 210.35K |
Aug 1 - Aug 2
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
$3.82 | -$45,122.65 |
—
| 210.35K |
Jul 7
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
$3.88 | -$474,702.96 |
—
| 210.35K |
Jul 3 - Jul 6
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.